相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cisplatin nephrotoxicity: new insights and therapeutic implications
Chengyuan Tang et al.
NATURE REVIEWS NEPHROLOGY (2023)
Maslinic Acid Attenuates Ischemia/Reperfusion-Induced Acute Kidney Injury by Suppressing Inflammation and Apoptosis Through Inhibiting NF-?B and MAPK Signaling Pathway
Wenjuan Sun et al.
FRONTIERS IN PHARMACOLOGY (2022)
Silibinin ameliorates cisplatin-induced acute kidney injury via activating Nfe2l1-mediated antioxidative response to suppress the ROS/MAPK signaling pathway
Fang Yang et al.
JOURNAL OF MOLECULAR HISTOLOGY (2022)
d-Borneol enhances cisplatin sensitivity via autophagy dependent EMT signaling and NCOA4-mediated ferritinophagy
Jinxiu Li et al.
PHYTOMEDICINE (2022)
Loganin Attenuates the Severity of Acute Kidney Injury Induced by Cisplatin through the Inhibition of ERK Activation in Mice
Dong-Uk Kim et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Saikosaponin D Attenuates Pancreatic Injury Through Suppressing the Apoptosis of Acinar Cell via Modulation of the MAPK Signaling Pathway
Caixia Li et al.
FRONTIERS IN PHARMACOLOGY (2021)
Acute kidney injury
John A. Kellum et al.
NATURE REVIEWS DISEASE PRIMERS (2021)
Flavonoid fisetin alleviates kidney inflammation and apoptosis via inhibiting Src-mediated NF-κB p65 and MAPK signaling pathways in septic AKI mice
Qian Ren et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
Nuclear receptor PXR targets AKR1B7 to protect mitochondrial metabolism and renal function in AKI
Xiaowen Yu et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
Madecassoside Protects Against LPS-Induced Acute Lung Injury via Inhibiting TLR4/NF-κB Activation and Blood-Air Barrier Permeability
Lu-Yuan Peng et al.
FRONTIERS IN PHARMACOLOGY (2020)
Madecassoside inhibits estrogen deficiency-induced osteoporosis by suppressing RANKL-induced osteoclastogenesis
Qingqing Wang et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2019)
Madecassoside prevents acute liver failure in LPS/D-GalN-induced mice by inhibiting p38/NF-κB and activating Nrf2/HO-1 signaling
Wei Wang et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
Hypoxia-inducible factor prolyl hydroxylase inhibitor roxadustat (FG-4592) protects against cisplatin-induced acute kidney injury
Yunwen Yang et al.
CLINICAL SCIENCE (2018)
Celastrol ameliorates cisplatin nephrotoxicity by inhibiting NF-kappa B and improving mitochondrial function
Xiaowen Yu et al.
EBIOMEDICINE (2018)
Signaling pathway of MAPK/ERK in cell proliferation, differentiation, migration, senescence and apoptosis
Yu Sun et al.
JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION (2015)
Protective effects of madecassoside against Doxorubicin induced nephrotoxicity in vivo and in vitro
Zhonghao Su et al.
SCIENTIFIC REPORTS (2015)
Neuroprotective effects of madecassoside against focal cerebral ischemia reperfusion injury in rats
Yuan Luo et al.
BRAIN RESEARCH (2014)
Acute kidney injury-epidemiology, outcomes and economics
Oleksa Rewa et al.
NATURE REVIEWS NEPHROLOGY (2014)
Pathophysiology of Cisplatin-Induced Acute Kidney Injury
Abdullah Ozkok et al.
BIOMED RESEARCH INTERNATIONAL (2014)
The Water-Soluble Triptolide Derivative PG490-88 Protects against Cisplatin-Induced Acute Kidney Injury
Hyun-Jung Kim et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2014)
In vivo disposition and metabolism of madecassoside, a major bioactive constituent in Centella asiatica (L.) Urb.
Dan-dan Leng et al.
JOURNAL OF ETHNOPHARMACOLOGY (2013)
Tumour heterogeneity and drug resistance: Personalising cancer medicine through functional genomics
Alvin J. X. Lee et al.
BIOCHEMICAL PHARMACOLOGY (2012)
The MAPK cascades: Signaling components, nuclear roles and mechanisms of nuclear translocation
Alexander Plotnikov et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2011)
Madecassoside suppresses LPS-induced TNF-α. production in cardiomyocytes through inhibition of ERK, p38, and NF-κB activity
Wei Cao et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2010)
MAPK signaling in inflammation-associated cancer development
Pengyu Huang et al.
PROTEIN & CELL (2010)
TLR4 signaling mediates inflammation and tissue injury in nephrotoxicity
Binzhi Zhang et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2008)
Cisplatin nephrotoxicity: Mechanisms and renoprotective strategies
N. Pabla et al.
KIDNEY INTERNATIONAL (2008)
Autophagy is associated with apoptosis in cisplatin injury to renal tubular epithelial cells
Cheng Yang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2008)
The pathological role of Bax in cisplatin nephrotoxicity
Q. Wei et al.
KIDNEY INTERNATIONAL (2007)
Cisplatin-induced acute renal failure is associated with an increase in the cytokines interleukin (IL)-1β, IL-18, IL-6, and neutrophil infiltration in the kidney
Sarah Faubel et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
MEK inhibitor, U0126, attenuates cisplatin-induced renal injury by decreasing inflammation and apoptosis
SK Jo et al.
KIDNEY INTERNATIONAL (2005)
Role of p53 in cisplatin-induced tubular cell apoptosis: dependence on p53 transcriptional activity
M Jiang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2004)
Interleukin-10 inhibits ischemic and cisplatin-induced acute renal injury
JP Deng et al.
KIDNEY INTERNATIONAL (2001)
分享论文
